First,
as part of the original Health and Nutrition Advisory Board and now
as our own nutrition consultant. Her love for Matol stems from a similarity
in missions. Hers is to impact the health and well-being of all her clients and
Matol Distributors by promoting good nutrition and physical activity. Matol’s
is to Impact World Health. Dr. Clark says that she relies on the knowledge of
Matol Distributors to take her message to hundreds of others who need assistance
changing bad health habits to good ones.
Dr. Clark is currently Director
of Sports Nutrition at Penn State University. She counsels over 800 varsity
athletes from 29 sports. She is also the spokesperson for the United States
Soccer Federation and a Fellow of the American College of Sports Medicine, the
largest group of sports medicine professionals in the world. In 1998, she was
elected as a Board of Trustee member to that group.
Georges Morisset, Pht.
brings years of experience in 
the
sports medicine field to the table, and is an invaluable ally in the mission
to Impact World Health. His impressive resume includes having worked with professional
hockey teams, as well as his work with athletes at the Pan-American Games and
the 1972 Olympic Games in Munich.
Thirty years of dedicated
service to his profession has brought Georges credibility and respect. His advice
has long been sought on a variety of health issues. Georges has had an interest
in nutrition and supplements since he was a young man, and he is committed to
helping Matol Distributors make sense of the wealth of information that exists
in the industry today.
Dr. Victor Manuel Santander, M.D., Ph.D., received his M.D. in November
1958 from the
National 
Autonomous
University of Mexico. He also has three Ph.D.’s in Biochemistry (1960),
Neurophysiology (1963), and Pharmacology (1965) from the National Autonomous
University of Mexico.
Dr. Santander has been in private practice for more than 40 years in the field
of Endocrinology, Virology and Immunology. Dr. Santander was a past Researcher
for the Department of Immunology (Tumors) at the Max Planck Institute in Freiburg,
Germany. Currently, he is the Director of the Immunology Institute in Mexico
City and a Research Professor for the Occidental Institute Research Foundation
in British Columbia, Canada.
Dr. Santander is the author of many original research publications and has written
various books focusing on Human Pharmacology and Neurophysiology.His first scholarly
publication, Dolor y Conducta 1958 Libros de Mexico S.A., is still used by students
as reference material for pain management. Dr. Santander was the first Latin-American
to discover a new antibiotic and has given many medical conferences in various
countries.
Robert
A. Murgita, Ph.D. is an internationally recognized expert in immunology and
immuno-therapeutic
proteins. Dr. Murgita has held academic positions at the State University New
York (SUNY) at Buffalo; the Mayo Clinic in Rochester, Minnesota; the University
of Uppsala and Karolinska Institutet in Stockholm, Sweden; and presently McGill
University in Montreal, Canada.
Dr. Murgita holds the position of Full Professor of Immunology at McGill University and has held various important administrative positions at this institution, including 10 years as the Chairman of the Department of Microbiology and Immunology, Medical Scientist at McGill’s two major teaching hospitals (the Montreal General Hospital and the Royal Victoria Hospital), and Director of the Office of Biotechnology.
He has held the Canadian Pacific Chair in Biotechnology, and as such, was the most prominent spokesperson for biotechnology at McGill and its affiliated research hospitals. As CP Chair, he created the first University-based biotechnology center in Canada: the Sheldon Biotechnology Center.
In 1994, he founded a successful
U.S.-based private biotechnology company that focuses on the development of
immuno-therapeutic drugs. This company currently has candidate therapeutics
in human clinical trials. He is the author of more than 100 papers and abstracts
in internationally recognized scientific journals and international conferences.
Dr. Murgita has supervised more than 30 graduate students who have obtained
Masters and Ph.D. degrees, and post-doctoral fellowships. Dr. Murgita is the
named inventor on more than 20 U.S. and international patents relating to immuno-therapeutic
proteins and their use in the treatment of various diseases.
Return
to Main Page